The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

LY-121860     1-(4-chlorophenyl)propan-2- amine

Synonyms: CHEMBL358967, SureCN267030, AG-K-91389, Ly-123362, p-Chloramphetamine, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of p-Chloramphetamine


Psychiatry related information on p-Chloramphetamine


High impact information on p-Chloramphetamine


Chemical compound and disease context of p-Chloramphetamine


Biological context of p-Chloramphetamine


Anatomical context of p-Chloramphetamine


Associations of p-Chloramphetamine with other chemical compounds


Gene context of p-Chloramphetamine


Analytical, diagnostic and therapeutic context of p-Chloramphetamine


  1. P-Chloramphetamine: Selective neurotoxic action in brain. Harvey, J.A., McMaster, S.E., Yunger, L.M. Science (1975) [Pubmed]
  2. Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine. Growdon, J.H. Neurology (1977) [Pubmed]
  3. Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant. Stenger, A., Couzinier, J.P., Briley, M. Psychopharmacology (Berl.) (1987) [Pubmed]
  4. Involvement of spinal serotonergic pathways in nociception but not in avoidance learning. Ogren, S.O., Berge, O.G., Johansson, C. Psychopharmacology (Berl.) (1985) [Pubmed]
  5. A comparative study of different amphetamines on copulatory behavior and stereotype activity in the female rat. Michanek, A., Meyerson, B.J. Psychopharmacology (Berl.) (1977) [Pubmed]
  6. Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Matsuno, K., Senda, T., Matsunaga, K., Mita, S., Kaneto, H. Psychopharmacology (Berl.) (1993) [Pubmed]
  7. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion. Ruotsalainen, S., Miettinen, R., MacDonald, E., Koivisto, E., Sirviö, J. Psychopharmacology (Berl.) (2000) [Pubmed]
  8. The pharmacology of impulsive behaviour in rats VII: the effects of serotonergic agonists and antagonists on responding under a discrimination task using unreliable visual stimuli. Evenden, J.L. Psychopharmacology (Berl.) (1999) [Pubmed]
  9. p-Chlorophenylalanine and p-chloroamphetamine pretreatment of apomorphine-challenged rats: effects on solitary and social behavior. Chow, H.L., Beck, C.H. Eur. J. Pharmacol. (1984) [Pubmed]
  10. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat. Ogren, S.O. Pharmacol. Biochem. Behav. (1982) [Pubmed]
  11. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Salomon, L., Lanteri, C., Glowinski, J., Tassin, J.P. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  12. Partial characterization of a renin-releasing factor from plasma and hypothalamus. Van de Kar, L.D., Urban, J.H., Brownfield, M.S., Simmons, W.H. Hypertension (1987) [Pubmed]
  13. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons. Reith, M.E., Sershen, H., Allen, D.L., Lajtha, A. Mol. Pharmacol. (1983) [Pubmed]
  14. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. Gardier, A.M., Moratalla, R., Cuéllar, B., Sacerdote, M., Guibert, B., Lebrec, H., Graybiel, A.M. J. Neurochem. (2000) [Pubmed]
  15. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Misane, I., Ogren, S.O. Neuropsychopharmacology (2000) [Pubmed]
  16. The effects of p-chloroamphetamine administration on locomotor activity and serotonin in neonatal and adult rats. Lucot, J.B., Horwitz, J., Seiden, L.S. J. Pharmacol. Exp. Ther. (1981) [Pubmed]
  17. p-Chloroamphetamine antagonism of cobaltous chloride-induced hypothermia in mice. Burke, D.H., Brooks, J.C., Ryan, R.P., Treml, S.B. Eur. J. Pharmacol. (1979) [Pubmed]
  18. Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice. Sugimoto, Y., Ohkura, M., Inoue, K., Yamada, J. Eur. J. Pharmacol. (2001) [Pubmed]
  19. Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones. Ogren, S.O., Ross, S.B. Acta pharmacologica et toxicologica. (1977) [Pubmed]
  20. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter. Kramer, H.K., Poblete, J.C., Azmitia, E.C. Neuropsychopharmacology (1997) [Pubmed]
  21. Central serotonergic influences on renal electrolyte and water excretion. Stein, J.M., Lind, R.W., Johnson, A.K. Neuropharmacology (1987) [Pubmed]
  22. Development of tolerance to the antinociceptive effect of metergoline. Fasmer, O.B., Berge, O.G., Hole, K. Psychopharmacology (Berl.) (1987) [Pubmed]
  23. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations. Miller, K.J., Anderholm, D.C., Ames, M.M. Biochem. Pharmacol. (1986) [Pubmed]
  24. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Fiorella, D., Helsley, S., Lorrain, D.S., Rabin, R.A., Winter, J.C. Psychopharmacology (Berl.) (1995) [Pubmed]
  25. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. Dewar, K.M., Grondin, L., Carli, M., Lima, L., Reader, T.A. J. Neurochem. (1992) [Pubmed]
  26. Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats. Champney, T.H., Matthews, R.T. J. Pineal Res. (1991) [Pubmed]
  27. Microglial response to degeneration of serotonergic axon terminals. Wilson, M.A., Molliver, M.E. Glia (1994) [Pubmed]
  28. Serotoninergic and non-serotoninergic responses of phrenic motoneurones to raphe stimulation in the cat. Lalley, P.M. J. Physiol. (Lond.) (1986) [Pubmed]
  29. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. Martín, F., Artigas, F. J. Neurochem. (1992) [Pubmed]
  30. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Schmidt, C.J., Levin, J.A., Lovenberg, W. Biochem. Pharmacol. (1987) [Pubmed]
  31. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. Bhat, R.V., Baraban, J.M. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
  32. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine. McQuade, R., Sharp, T. Neuroscience (1995) [Pubmed]
  33. Analgesia induced by brief footshock is inhibited by 5-hydroxytryptamine but unaffected by antagonists of 5-hydroxytryptamine or by naloxone. Tricklebank, M.D., Hutson, P.H., Curzon, G. Neuropharmacology (1982) [Pubmed]
  34. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. Mamounas, L.A., Altar, C.A., Blue, M.E., Kaplan, D.R., Tessarollo, L., Lyons, W.E. J. Neurosci. (2000) [Pubmed]
  35. In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. Grider, M.H., Mamounas, L.A., Le, W., Shine, H.D. J. Neurosci. Res. (2005) [Pubmed]
  36. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors. Yamada, J., Sugimoto, Y., Yoshikawa, T. Eur. J. Pharmacol. (1998) [Pubmed]
  37. 5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Azmitia, E.C., Rubinstein, V.J., Strafaci, J.A., Rios, J.C., Whitaker-Azmitia, P.M. Brain Res. (1995) [Pubmed]
  38. Effects of p-chloroamphetamine on release of [3H]gamma-aminobutyric acid from slices of rat caudate-putamen. Meyer, D.K., Holland, A., Lais, A., Szabo, B. Eur. J. Pharmacol. (1991) [Pubmed]
  39. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Zetterström, T.S., Pei, Q., Madhav, T.R., Coppell, A.L., Lewis, L., Grahame-Smith, D.G. Neuropharmacology (1999) [Pubmed]
WikiGenes - Universities